Skip to content
Equity Capital Market
  • Privacy Policy
  • Start Here
  • Research
    • LPTH case study
    • PLUG case study
    • STDN case study
  • IPO & Public Offerings
  • Economy & Macro
  • Latest
  • Stock Market
  • Market Education
  • Energy & Commodities
  • Capital Markets
  • Federal Reserve & Rates
  • About
  • Contact

Avatar photoBruno M.

Bruno M. founded ECMSource to make capital markets understandable for everyday investors. Coverage here is built from primary sources — SEC filings, Federal Reserve releases, and company disclosures — with automation handling the research legwork so it stays broad and current. Bruno sets the site's editorial standards; every number published traces back to a named source.

EPS, Diluted EPS, and Non-GAAP Earnings Explained

September 12, 2026May 1, 2026 by Bruno M.
EPS, Diluted EPS, and Non-GAAP Earnings Explained

Learn how basic EPS, diluted EPS, and non-GAAP adjusted earnings are calculated—and why each number tells a different story during earnings season.

Categories Market Education Tags diluted EPS, earnings per share, earnings season, eps, investing basics, non-GAAP earnings

Blackstone’s $10B Credit Fund: How Private Lending Hit $520B

September 12, 2026May 1, 2026 by Bruno M.
Blackstone’s $10B Credit Fund: How Private Lending Hit $520B

Blackstone’s Capital Opportunities Fund V closed oversubscribed at $10B. Private credit now rivals the entire high-yield bond market—here’s who’s winning and what risks regulators see.

Categories Capital Markets Tags alternative assets, blackstone credit, capital markets, direct lending, private credit

Merck Raises 2026 Guidance After Q1 Revenue Beat, Despite $9B Deal Charge

September 12, 2026May 1, 2026 by Bruno M.
Merck Raises 2026 Guidance After Q1 Revenue Beat, Despite $9B Deal Charge

Merck Q1 2026: $16.3B revenue beat, guidance raised. A $9B acquisition charge drove a GAAP loss, but Winrevair growth signals strong underlying fundamentals.

Categories Stock Market Tags drug stocks Q1 2026, keytruda, merck earnings, MRK stock, pharmaceutical stocks, stock market

How Short Selling Works: Short Interest and Squeezes

October 24, 2026May 1, 2026 by Bruno M.
How Short Selling Works: Short Interest and Squeezes

Short selling lets investors profit from falling prices. Learn how it works, what short interest means, and what triggers a short squeeze.

Categories Market Education Tags investing basics, margin trading, short interest, short selling, short squeeze, stock market mechanics

30-Year Treasury Near 5%: The Forces Keeping U.S. Borrowing Costs High

September 12, 2026May 1, 2026 by Bruno M.
30-Year Treasury Near 5%: The Forces Keeping U.S. Borrowing Costs High

The 30-year Treasury yield stands at 4.987% on April 30, 2026 — nearly 5% — as term premium surges on sticky inflation, rising supply, and fading foreign demand for US debt.

Categories Federal Reserve & Rates Tags bonds, capital markets, federal reserve, interest rates, treasury yields

Eli Lilly Q1 2026: Revenue Surges 56% as GLP-1 Boom Deepens

September 12, 2026April 30, 2026 by Bruno M.
Eli Lilly Q1 2026: Revenue Surges 56% as GLP-1 Boom Deepens

Eli Lilly beat Q1 2026 estimates with $19.8B revenue (+56%), EPS of $8.26 (+170%), driven by Mounjaro, Zepbound, and newly launched oral pill Foundayo.

Categories Stock Market Tags eli lilly earnings, glp-1 drugs, mounjaro zepbound, obesity drug, pharmaceutical stocks, stock market

Options Greeks Explained: Delta, Gamma, Theta, and Vega

September 17, 2026April 30, 2026 by Bruno M.
Options Greeks Explained: Delta, Gamma, Theta, and Vega

Learn what the five options Greeks actually mean — delta, gamma, theta, vega, and rho — with worked examples, a data table, and charts that show how each measure changes in real market conditions.

Categories Market Education Tags delta gamma theta vega, investing basics, options explained, options greeks, options trading

Lincoln International Files for a Rare NYSE IPO

September 12, 2026April 30, 2026 by Bruno M.
Lincoln International Files for a Rare NYSE IPO

Lincoln International filed an S-1 with the SEC to list on NYSE under ticker LCLN. With $783.8M in 2025 revenue and Goldman Sachs and Morgan Stanley as underwriters, here’s what it means for capital markets.

Categories Capital Markets, IPO & Public Offerings Tags capital markets, investment bank ipo, LCLN, lincoln international ipo, M&A advisory, NYSE 2026

NXP Semiconductors Jumps 26% on Best Day Since 2010 IPO

September 12, 2026April 30, 2026 by Bruno M.
NXP Semiconductors Jumps 26% on Best Day Since 2010 IPO

NXP Semiconductors surged 26% — its best day since listing in 2010 — as Q1 earnings beat estimates and Q2 guidance of up to $3.55B signaled a chip recovery led by auto and AI.

Categories Stock Market Tags automotive chips, chip stocks earnings, earnings season, nxp semiconductors, semiconductor stocks, stock market

Options 101: Calls, Puts, Strike Price, and Premium Explained

September 12, 2026April 30, 2026 by Bruno M.
Options 101: Calls, Puts, Strike Price, and Premium Explained

Learn how options work — what calls and puts are, how premiums are priced, and the difference between intrinsic and extrinsic value. Includes payoff diagrams.

Categories Market Education Tags calls and puts, investing basics, options explained, options premium, options trading, stock market
Older posts
Newer posts
← Previous Page1 … Page84 Page85 Page86 … Page111 Next →

Explore ECMSource

New here? Begin with our guide to the site, then explore the subjects that match what you want to understand.

  • Start Here
  • Market Education
  • Stock Market
  • Capital Markets
  • Federal Reserve & Rates

Recent Posts

  • Anthropic Files Form S-1 for Nasdaq IPO Under Ticker ANT
  • Nvidia AI Software GPU Licensing Fees: How the Model Works
  • Spinoffs vs. Split-Offs vs. Carve-Outs: Corporate Divestitures
  • Marvell Doubles Credit Facility to $3B With $2B Accordion
  • Lockheed Martin Posts Record $292B Backlog, Raises 2026 Outlook

Subscribe to Our Newsletter

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox, every month.

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

  • Privacy Policy
  • Editorial Policy
  • Corrections Policy
  • Financial Disclaimer
  • Contact
  • About Bruno M.
  • Investor Tools
© 2026 Equity Capital Market • Built with GeneratePress